PCN82 Cost-Effectiveness Analysis of Erlotinib Versus Platinum Based Chemotherapy as First-Line Treatment of Non-Small Cell Lung Cancer EGFR Activating Mutations
Abstract
Authors
P. Garrido G. López-Vivanco R. Rosell B. Espinós A. Castro-Gomez